Advertisement
YOU ARE HERE: LAT HomeCollectionsVascular Intervention Inc
IN THE NEWS

Vascular Intervention Inc

FEATURED ARTICLES
BUSINESS
December 7, 1988 | United Press International
Eli Lilly and Co. said it will acquire Devices for Vascular Intervention Inc. of Redwood City, Calif., in a multimillion-dollar deal. Lilly described DVI as the leading developer and manufacturer of catheter systems for the treatment of cardiovascular disease by removal of vascular plaque.
ARTICLES BY DATE
BUSINESS
December 7, 1988 | United Press International
Eli Lilly and Co. said it will acquire Devices for Vascular Intervention Inc. of Redwood City, Calif., in a multimillion-dollar deal. Lilly described DVI as the leading developer and manufacturer of catheter systems for the treatment of cardiovascular disease by removal of vascular plaque.
Advertisement
BUSINESS
June 21, 1994 | From Times Staff and Wire Reports
Lilly to Spin Off Five Divisions: Indianapolis-based Eli Lilly & Co. said it plans to form a new public company out of five of its medical device and diagnostics businesses. Lilly said the five companies will be known as Guidant Corp. if the plan is approved by federal regulators. The first stock offering is expected during the fourth quarter of this year. The spinoff is part of a restructuring implemented after Randall Tobias took over as chairman and CEO last summer.
NEWS
March 15, 1987 | WILLIAM C. HIDLAY, Associated Press
A California doctor's experimental "Roto-Rooter" has successfully cut fatty deposits from patients' clogged arteries, and authorities say the device is a promising development in fighting the crippling blockages. The new device, a rotating drill smaller around than a ballpoint pen refill, and the experimental procedure, called atherectomy, were designed by Dr. John Simpson, a cardiologist in Redwood City.
BUSINESS
October 12, 1993 | DAVID R. OLMOS, TIMES STAFF WRITER
In the latest in a series of major cutbacks in the pharmaceuticals industry, Eli Lilly & Co. on Monday said it will slash its worldwide employment by 4,000 positions over the next few years, mainly through early retirements. Indianapolis-based Lilly joins other drug industry giants such as Merck & Co., Marion Merrill Dow Inc. and Johnson & Johnson, which have been forced to cut their payrolls.
Los Angeles Times Articles
|